Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Are Buying Dynavax Technologies Corporation (DVAX)

Page 1 of 2

Is Dynavax Technologies Corporation (NASDAQ:DVAX) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of research. Hedge funds spend millions of dollars on Ivy League graduates, expert networks, and get tips from industry insiders. They fail miserably sometimes but historically their consensus stock picks outperformed the market after adjusting for known risk factors.

Dynavax Technologies Corporation (NASDAQ:DVAX) was in 32 hedge funds’ portfolios at the end of the third quarter of 2015. DVAX investors should be aware of an increase in hedge fund sentiment lately. There were 27 hedge funds in our database with DVAX holdings at the end of the previous quarter. At the end of this article we will also compare DVAX to other stocks including Infoblox Inc (NYSE:BLOX), Evolent Health Inc (NYSE:EVH), and Genesis Healthcare Inc (NYSE:GEN) to get a better sense of its popularity.

Follow Dynavax Technologies Corp (NASDAQ:DVAX)
Trade (NASDAQ:DVAX) Now!

Keeping this in mind, we’re going to take a peek at the latest action surrounding Dynavax Technologies Corporation (NASDAQ:DVAX).

What does the smart money think about Dynavax Technologies Corporation (NASDAQ:DVAX)?

At Q3’s end, a total of 32 of the hedge funds tracked by Insider Monkey held long positions in this stock, a change of 19% from the second quarter. With hedgies’ capital changing hands, there exists a select group of noteworthy hedge fund managers who were boosting their stakes significantly (or already accumulated large positions).

When looking at the institutional investors followed by Insider Monkey, Samuel Isaly’s OrbiMed Advisors has the biggest position in Dynavax Technologies Corporation (NASDAQ:DVAX), worth close to $60.7 million, accounting for 0.6% of its total 13F portfolio. On OrbiMed Advisors’s heels is Amici Capital, managed by Paul Orlin and Alex Porter, which holds a $48.6 million position; 2.3% of its 13F portfolio is allocated to the stock. Remaining hedge funds and institutional investors that are bullish contain Ken Griffin’s Citadel Investment Group, Brian Ashford-Russell and Tim Woolley’s Polar Capital and Kevin Kotler’s Broadfin Capital.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!